Respiratory syncytial virus-attributable hospitalizations among adults in high- and middle-income countries: application of the Global Burden of Disease framework
Authors:
- Katrin BurkartKBKatrin Burkart
- Caihua LiangCLCaihua Liang
- Quinn RaffertyQRQuinn Rafferty
- Catherine W. GillespieCGCatherine W. Gillespie
- Susan McLaughlinSMSusan McLaughlin
- Andrei OrosAOAndrei Oros
- Jam SubaJSJam Suba
- Duilia BrunoDBDuilia Bruno
- Marion FaheyMFMarion Fahey
- Ana G. GrajalesAGAna G. Grajales
- Mariana HaebererMHMariana Haeberer
- Caroline LadeCLCaroline Lade
Open Access
- 16 June 2025
- journal article
- Published by Elsevier in eClinicalMedicine
- Vol. 85
Abstract
No abstract availableKeywords
Funding Information
- Pfizer
This publication has 33 references indexed in Scilit:
- Estimated Incidence of Hospitalizations and Deaths Attributable to Respiratory Syncytial Virus Infections Among Adults in Germany Between 2015 and 2019Infectious Diseases and Therapy, 2024
- Estimation of Symptomatic Respiratory Syncytial Virus Infection Incidence in Adults in Multiple Countries: A Time-Series Model-Based Analysis ProtocolInfectious Diseases and Therapy, 2024
- Estimated Respiratory Syncytial Virus-Related Hospitalizations and Deaths Among Children and Adults in Spain, 2016–2019Infectious Diseases and Therapy, 2024
- Incidence of Respiratory Syncytial Virus Infection in Older Adults: Limitations of Current DataInfectious Diseases and Therapy, 2023
- Diagnosis of Respiratory Syncytial Virus in Adults Substantially Increases When Adding Sputum, Saliva, and Serology Testing to Nasopharyngeal Swab RT–PCRInfectious Diseases and Therapy, 2023
- Adjusting for Case Under-Ascertainment in Estimating RSV Hospitalisation Burden of Older Adults in High-Income Countries: a Systematic Review and Modelling StudyInfectious Diseases and Therapy, 2023
- Low Levels of RSV Testing Among Adults Hospitalized for Lower Respiratory Tract Infection in the United StatesInfectious Diseases and Therapy, 2023
- Global, regional and national estimates of influenza-attributable ischemic heart disease mortalityeClinicalMedicine, 2022
- Respiratory Syncytial Virus and Associations With Cardiovascular Disease in AdultsJACC, 2018
- Seasonal Influenza Infections and Cardiovascular Disease MortalityJAMA Cardiology, 2016